Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections

NCT03189537 PHASE3 COMPLETED

The purpose of the study was to evaluate efficacy of prophylactic Ingavirin intake by people having contact with sick people infected with influenza and other acute respiratory viral infections

Details

Lead sponsor	Valenta Pharm JSC
Phase	PHASE3
Status	COMPLETED
Enrolment	400
Start date	Sun Oct 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Oct 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Influenza, Human
• Acute Respiratory Infection
• Common Cold
• Flu
• Viral Infection

Interventions

• Ingavirin (Imidazolyl Ethanamide Pentandioic Acid)
• Placebo oral capsule

Countries

Russia